Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Cancer Research UK, a leading membership organisation based in Great Britain, has been at the forefront of cancer research since its establishment in 2002. With a commitment to saving lives through innovative research and public engagement, the organisation operates extensively across the UK, focusing on various aspects of cancer prevention, diagnosis, and treatment.
As a prominent player in the membership organisation services sector, Cancer Research UK uniquely combines scientific research with community involvement, offering a range of services that include funding groundbreaking studies and providing vital information to the public. The organisation has achieved significant milestones, including the development of life-saving treatments and pioneering research initiatives that have transformed cancer care.
Recognised for its impactful contributions to the field, Cancer Research UK continues to lead the way in cancer research, making strides towards a future where more people survive cancer than ever before.
28
DitchCarbon score
+1 vs industry average
Cancer Research UK’s score of 28 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Cancer Research UK?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medium
Membership Services has typical carbon intensity
Industry performance
0.199
20182025
The Membership Services industry has reduced its overall emissions by 37% since 2018
Reported emissions
No reported emissions data is available for Cancer Research UK yet.
Cancer Research UK's reported carbon emissions
Cancer Research UK, a UK-based membership organisation, has not disclosed its absolute Scope 1, 2, or 3 carbon emissions. However, the organisation has committed to reducing all its emissions (Scope 1, 2, and 3) by 50% by 2030, using 2019 levels as a baseline for Scope 1 and 2 emissions. Cancer Research UK aims to achieve net zero emissions by 2050. The organisation is developing a comprehensive Scope 3 map in 2022 to establish its Scope 3 baseline.
Assessing Cancer Research UK as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Cancer Research UK and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Cancer Research UK’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Cancer Research UK9 days ago
28
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more